BIOS Capital Management »

Actuate Therapeutics shares owned by BIOS Capital Management

Quarter-by-quarter ownership of Actuate Therapeutics (ACTU) shares owned by BIOS Capital Management from 13F filings

Historical chart of BIOS Capital Management investment in Actuate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Actuate Therapeutics held by BIOS Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actuate Therapeutics by BIOS Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $67M 10M 6.69
2025-06-30 $61M 10M 6.11
2025-03-31 $67M 9.9M 6.77
2024-12-31 $79M 9.9M 7.96